Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts - Zhao, Xiao‐Su; Liu, Yan‐Rong; Xu, Lan‐Ping; Wang, Yu; Zhang, Xiao‐Hui; Chen, Huan; Chen, Yu‐Hong; Han, Wei; Sun, Yu‐Qian; Yan, Chen‐Hua; Mo, Xiao‐Dong; Wang, Ya‐Zhe; et al. (American journal of hematology, 2019)
Keywords: Acute lymphoblastic leukemia; Adolescent; Adult; Allografts; Child; Child, Preschool; Disease-Free Survival; Female; Flow Cytometry; Hematology; Humans; Leukemia; Lymphatic leukemia; Male; Middle Aged; Minimal residual disease; Multivariate analysis; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood; Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy; Preoperative Care; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Time Factors